Scientific Leadership Development Award
Scientific Leadership Development Award supports emerging HVTN scientists with mentoring, professional development, and manuscript work to prepare them to lead HIV vaccine clinical trials.
Funder: HIV Vaccine Trials Network
Due Dates: August 1, 2026 (Applications open) | October 30, 2026, 11:59 pm Pacific Time (Application deadline) | December 15, 2026 (Notification by)
Funding Amounts: Up to 20% FTE support for 12 months; up to 6 scientists annually
Summary: Supports emerging HVTN scientists through mentoring, professional development, and manuscript work to prepare them to lead HIV vaccine clinical trials.
Key Information: Applicants must be affiliated with an HVTN Core site or a site with active HVTN studies.
Description
The HIV Vaccine Trials Network (HVTN) Scientific Leadership Development Award prepares emerging scientists to chair or co-chair HVTN protocols. Anticipating an increase in HIV vaccine trials, HVTN supports early career scientists with strong research interests, a reputation for excellence at their clinical sites, and a career trajectory toward trial leadership. Developing first-author capacity is a central priority.
Participants create an individual professional development plan, complete a scientific manuscript using HVTN data, and receive coaching and sponsorship. Mentoring can address first authorship, protocol development and implementation, translational research and immunology, and statistical analysis. The program supports scientists through their affiliated sites and aims to build their readiness to lead HIV vaccine clinical trials.
